论文信息 - EORTC 18991 phase III trial: Long-term adjuvant pegylated interferon-α2b (PEG-IFN) versus observation in resected stage III melanoma: Long-term results at 7.6-years follow-up. - 字舞流文

EORTC 18991 phase III trial: Long-term adjuvant pegylated interferon-α2b (PEG-IFN) versus observation in resected stage III melanoma: Long-term results at 7.6-years follow-up.

D. Schadendorf | R. Dummer | M. Gore | A. Eggermont | A. Testori | C. Punt | R. MacKie | P. Patel | S. Suciu | U. Keilholz | C. Punt | M. Santinami | A. Spatz | W. Kruit | J. Marsden | A. Eggermont